IRTC
iRhythm Holdings, Inc.
$113.65
+0.87%
$3.7B
No data for this timeframe.
Vol
Market Cap$3.7B
Cap SizeMid Cap
Analyst ConsensusStrong Buy (90%)
Inst. Holders50 funds
Inst. Value$2.9B
Inst. Activity26 buys / 19 sells
Insider Activity1B / 22S
Insider Net $-$11.9M
SEC Reports12
Press Releases1
Recent Activity
Jun 5, 2026
SEC
iRhythm Holdings disclosed a binding settlement agreement to resolve a securities class action for $45 million, with the
8-K — Impact 5/10
Jun 2, 2026
Insider
Shrishrimal Sumi sold 1,716 shares
EVP, Chief Risk Officer @ $108.19 ($185.7K)
May 29, 2026
Insider
Shrishrimal Sumi was granted 133 shares
EVP, Chief Risk Officer @ $96.82 ($12.9K)
May 29, 2026
Insider
Blackford Quentin S. was granted 178 shares
President and CEO @ $96.82 ($17.2K)
May 28, 2026
SEC
iRhythm Holdings held its 2026 Annual Meeting on May 27, 2026, with 89.69% of shares represented. Stockholders approved
8-K — Impact 2/10
May 12, 2026
SEC
Director Abhijit Talwalkar exercised 5,312 options at $10.71, simultaneously sold 940 shares on the open market at ~$116
CLUSTER — Impact 2/10
Inst.
RTW INVESTMENTS, LP — ADD
1,668,500 shares ($196.9M)
Inst.
FMR LLC — DOUBLED
1,361,919 shares ($160.7M)
Price Targets
$178.93
+57.4% upside
Strong Buy
Current $113.65
Low $147.00
Median $177.50
High $255.00
14 analysts
$147.00
$255.00
Analyst Ratings
9Strong Buy
10Buy
2Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 10, 2026 | BTIG | REITERATE | Buy → Buy |
| Jun 1, 2026 | Canaccord Genuity | MAINTAIN | Buy → Buy |
| May 18, 2026 | B of A Securities | MAINTAIN | Buy → Buy |
| May 4, 2026 | Citigroup | MAINTAIN | Buy → Buy |
| May 1, 2026 | Canaccord Genuity | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.00 | $-0.10 — $0.12 | 100% YoY | 10 |
| Next Q | $0.09 | $0.01 — $0.19 | 249% YoY | 10 |
| Current FY | $0.12 ▼ -8.6% | $-0.12 — $0.30 | 111% YoY | 10 |
| Next FY | $1.05 ▲ +0.8% | $0.76 — $1.51 | 800% YoY | 10 |
Latest Reports
BULLISH
8-K
5/10
iRhythm Holdings disclosed a binding settlement agreement to resolve a securities class action for $45 million, with the
Jun 5, 2026
NEUTRAL
8-K
2/10
iRhythm Holdings held its 2026 Annual Meeting on May 27, 2026, with 89.69% of shares represented. Stockholders approved
May 28, 2026
BULLISH
Press
7/10
iRhythm (IRTC) presented new real-world data at HRS 2026 showing that 26% of atrial fibrillation (AF) recurrences after
Apr 27, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $323.6M | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $212.0M | — |
| RTW INVESTMENTS, LP | $196.9M | ADD |
| Artisan Partners Limited Partnership | $171.2M | TRIM |
| VANGUARD CAPITAL MANAGEMENT LLC | $170.6M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 2, 2026 | Shrishrimal Sumi | SELL | $185.7K |
| May 29, 2026 | Shrishrimal Sumi | A | $12.9K |
| May 29, 2026 | Blackford Quentin | A | $17.2K |
| May 29, 2026 | Patterson Chad | A | $17.1K |
| May 29, 2026 | Turakhia Minang | A | $13.3K |
50 institutional holders with $2.9B total value (24,431,025 shares) as of 2026-Q1. Top holders: BlackRock,, VANGUARD, RTW. Net buying activity: 26 institutions added/increased vs 19 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 2,741,505 | $323.6M | 11.2% | — |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1,796,372 | $212.0M | 7.4% | — |
| 3 | RTW INVESTMENTS, LP | 1,668,500 | $196.9M | 6.8% | ADD +41.2% |
| 4 | Artisan Partners Limited Partnership | 1,450,907 | $171.2M | 5.9% | TRIM -41.1% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 1,445,710 | $170.6M | 5.9% | — |
| 6 | FMR LLC | 1,361,919 | $160.7M | 5.6% | DOUBLED +116.6% |
| 7 | Holocene Advisors, LP | 1,248,658 | $147.4M | 5.1% | ADD +82.7% |
| 8 | STATE STREET CORP | 788,302 | $93.0M | 3.2% | — |
| 9 | BNP Paribas Asset Management Holding S.A. | 762,062 | $89.9M | 3.1% | ADD +30.7% |
| 10 | FULLER & THALER ASSET MANAGEMENT, INC. | 674,698 | $79.6M | 2.8% | — |
| 11 | BLAIR WILLIAM & CO/IL | 628,385 | $74.2M | 2.6% | — |
| 12 | Point72 Asset Management, L.P. | 599,405 | $70.7M | 2.5% | DOUBLED +173.1% |
| 13 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 582,879 | $68.8M | 2.4% | — |
| 14 | D. E. Shaw & Co., Inc. | 554,266 | $65.4M | 2.3% | — |
| 15 | Capital Research Global Investors | 509,590 | $60.1M | 2.1% | TRIM -57.0% |
| 16 | Allspring Global Investments Holdings, LLC | 467,113 | $55.2M | 1.9% | — |
| 17 | BANK OF AMERICA CORP /DE/ | 432,539 | $51.0M | 1.8% | — |
| 18 | Polar Capital Holdings Plc | 421,612 | $49.8M | 1.7% | ADD +36.8% |
| 19 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 390,577 | $46.1M | 1.6% | ADD +99.2% |
| 20 | MACKENZIE FINANCIAL CORP | 371,475 | $43.8M | 1.5% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | ADD | 1,181,990 | 1,668,500 | +41.2% | $196.9M | 2026-Q1 |
| FMR LLC | DOUBLED | 628,766 | 1,361,919 | +116.6% | $160.7M | 2026-Q1 |
| Holocene Advisors, LP | ADD | 683,568 | 1,248,658 | +82.7% | $147.4M | 2026-Q1 |
| BNP Paribas Asset Management Holding S.A. | ADD | 583,014 | 762,062 | +30.7% | $89.9M | 2026-Q1 |
| Point72 Asset Management, L.P. | DOUBLED | 219,468 | 599,405 | +173.1% | $70.7M | 2026-Q1 |
| Capital Research Global Investors | TRIM | 1,184,746 | 509,590 | -57.0% | $60.1M | 2026-Q1 |
| Polar Capital Holdings Plc | ADD | 308,100 | 421,612 | +36.8% | $49.8M | 2026-Q1 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | ADD | 196,075 | 390,577 | +99.2% | $46.1M | 2026-Q1 |
| Invesco Ltd. | TRIM | 498,385 | 297,452 | -40.3% | $35.1M | 2026-Q1 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | ADD | 162,053 | 247,746 | +52.9% | $28.3M | 2026-Q1 |
| MORGAN STANLEY | ADD | 169,991 | 237,799 | +39.9% | $28.1M | 2026-Q1 |
| AMERIPRISE FINANCIAL INC | ADD | 123,621 | 236,786 | +91.5% | $27.9M | 2026-Q1 |
| BAMCO INC /NY/ | NEW | — | 183,900 | — | $21.7M | 2026-Q1 |
| FEDERATED HERMES, INC. | ADD | 106,407 | 149,459 | +40.5% | $17.6M | 2026-Q1 |
| Trexquant Investment LP | ADD | 78,653 | 111,311 | +41.5% | $13.1M | 2026-Q1 |
| WCM INVESTMENT MANAGEMENT, LLC | ADD | 73,292 | 108,078 | +47.5% | $12.3M | 2026-Q1 |
| WELLINGTON MANAGEMENT GROUP LLP | NEAR_EXIT | 408,256 | 90,460 | -77.8% | $10.7M | 2026-Q1 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | ADD | 47,898 | 61,681 | +28.8% | $7.3M | 2026-Q1 |
| CANADA PENSION PLAN INVESTMENT BOARD | ADD | 30,100 | 58,800 | +95.3% | $6.9M | 2026-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 103,900 | 53,800 | -48.2% | $6.3M | 2026-Q1 |
| Amundi | ADD | 33,410 | 49,575 | +48.4% | $5.9M | 2026-Q1 |
| Verition Fund Management LLC | ADD | 19,600 | 34,565 | +76.4% | $4.1M | 2026-Q1 |
| ENVESTNET ASSET MANAGEMENT INC | ADD | 23,204 | 32,134 | +38.5% | $3.8M | 2026-Q1 |
| VICTORY CAPITAL MANAGEMENT INC | TRIM | 43,215 | 22,172 | -48.7% | $2.6M | 2026-Q1 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | TRIM | 39,747 | 21,238 | -46.6% | $2.5M | 2026-Q1 |
18 unique insiders with 50 transactions. Net insider value: -$11.9M ($56.9K bought, $11.9M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | Shrishrimal Sumi | EVP, Chief Risk Officer | SELL | 1,716 | $108.19 | $185.7K |
| May 29, 2026 | Shrishrimal Sumi | EVP, Chief Risk Officer | AWARD | 133 | $96.82 | $12.9K |
| May 29, 2026 | Blackford Quentin S. | President and CEO | AWARD | 178 | $96.82 | $17.2K |
| May 29, 2026 | Patterson Chad | CHIEF COMM & PRODUCT OFFICER | AWARD | 177 | $96.82 | $17.1K |
| May 29, 2026 | Turakhia Minang | CHIEF MED/SCI OFCR EVP ADVTECH | AWARD | 137 | $96.82 | $13.3K |
| May 27, 2026 | TALWALKAR ABHIJIT Y | Director | AWARD | 1,573 | — | — |
| May 27, 2026 | YOOR BRIAN B | Director | AWARD | 1,573 | — | — |
| May 27, 2026 | OBOYLE KEVIN C | Director | AWARD | 1,573 | — | — |
| May 27, 2026 | Ling Karen | Director | AWARD | 1,573 | — | — |
| May 27, 2026 | MCGINNIS KAREN K | Director | AWARD | 1,573 | — | — |
| May 27, 2026 | Bodaken Bruce G. | Director | AWARD | 1,573 | — | — |
| May 27, 2026 | Bairey Merz Cathleen Noel | Director | AWARD | 1,573 | — | — |
| May 11, 2026 | TALWALKAR ABHIJIT Y | Director | BUY | 5,312 | $10.71 | $56.9K |
| May 11, 2026 | TALWALKAR ABHIJIT Y | Director | SELL | 940 | $116.05 | $109.1K |
| May 11, 2026 | TALWALKAR ABHIJIT Y | Director | EXERCISE | 5,312 | $10.71 | $56.9K |
| May 4, 2026 | Lawrence Brian Lee | Chief Technology Officer | SELL | 1,014 | $120.80 | $122.5K |
| Mar 16, 2026 | Smith Mervin | EVP Strategic Business Ops | SELL | 2,585 | $114.30 | $295.5K |
| Mar 12, 2026 | Patten Jason H | Director | AWARD | 2,218 | — | — |
| Mar 2, 2026 | Smith Mervin | EVP Strategic Business Ops | SELL | 752 | $128.44 | $96.6K |
| Mar 2, 2026 | Wilson Daniel G. | Chief Financial Officer | SELL | 755 | $128.44 | $97.0K |
| Mar 2, 2026 | Shrishrimal Sumi | EVP, Chief Risk Officer | SELL | 946 | $128.44 | $121.5K |
| Mar 2, 2026 | Patterson Chad | CHIEF COMM & PRODUCT OFFICER | SELL | 1,414 | $128.44 | $181.6K |
| Mar 2, 2026 | Blackford Quentin S. | President and CEO | SELL | 4,347 | $128.44 | $558.3K |
| Mar 2, 2026 | Turakhia Minang | CHIEF MED/SCI OFCR EVP ADVTECH | SELL | 1,487 | $128.45 | $191.0K |
| Mar 2, 2026 | Murphy Patrick Michael | CBO and CLO | SELL | 2,028 | $128.44 | $260.5K |
| Mar 2, 2026 | Rosenbaum Marc Wade | Chief Accounting Officer | SELL | 399 | $128.45 | $51.3K |
| Feb 25, 2026 | Freeman Sean Clinton | EVP, Strategy & Corp Devt | AWARD | 7,525 | — | — |
| Feb 25, 2026 | Rosenbaum Marc Wade | Chief Accounting Officer | SELL | 4,797 | $135.42 | $649.6K |
| Feb 25, 2026 | Wilson Daniel G. | Chief Financial Officer | AWARD | 8,361 | — | — |
| Feb 25, 2026 | Shrishrimal Sumi | EVP, Chief Risk Officer | AWARD | 5,518 | — | — |
| Feb 25, 2026 | Patterson Chad | CHIEF COMM & PRODUCT OFFICER | AWARD | 10,870 | — | — |
| Feb 25, 2026 | Murphy Patrick Michael | CBO and CLO | AWARD | 7,024 | — | — |
| Feb 25, 2026 | Rosenbaum Marc Wade | Chief Accounting Officer | AWARD | 2,508 | — | — |
| Feb 25, 2026 | Turakhia Minang | CHIEF MED/SCI OFCR EVP ADVTECH | AWARD | 10,034 | — | — |
| Feb 25, 2026 | Murphy Patrick Michael | CBO and CLO | SELL | 7,805 | $135.42 | $1.1M |
| Feb 25, 2026 | Blackford Quentin S. | President and CEO | AWARD | 31,842 | — | — |
| Feb 25, 2026 | Blackford Quentin S. | President and CEO | SELL | 25,540 | $135.42 | $3.5M |
| Feb 25, 2026 | Smith Mervin | EVP Strategic Business Ops | SELL | 4,041 | $135.42 | $547.2K |
| Feb 25, 2026 | Turakhia Minang | CHIEF MED/SCI OFCR EVP ADVTECH | SELL | 7,804 | $135.42 | $1.1M |
| Feb 25, 2026 | Wilson Daniel G. | Chief Financial Officer | SELL | 5,188 | $135.42 | $702.6K |
| Feb 25, 2026 | Shrishrimal Sumi | EVP, Chief Risk Officer | SELL | 6,217 | $135.42 | $841.9K |
| Feb 25, 2026 | Patterson Chad | CHIEF COMM & PRODUCT OFFICER | SELL | 8,967 | $135.42 | $1.2M |
| Feb 25, 2026 | Smith Mervin | EVP Strategic Business Ops | AWARD | 6,689 | — | — |
| Feb 24, 2026 | Smith Mervin | EVP Strategic Business Ops | SELL | 732 | $140.91 | $103.1K |
| Feb 24, 2026 | Rosenbaum Marc Wade | Chief Accounting Officer | AWARD | 9,210 | — | — |
| Feb 24, 2026 | Patterson Chad | CHIEF COMM & PRODUCT OFFICER | AWARD | 17,318 | — | — |
| Feb 24, 2026 | Blackford Quentin S. | President and CEO | AWARD | 46,687 | — | — |
| Feb 24, 2026 | Smith Mervin | EVP Strategic Business Ops | AWARD | 9,210 | — | — |
| Feb 24, 2026 | Turakhia Minang | CHIEF MED/SCI OFCR EVP ADVTECH | AWARD | 15,060 | — | — |
| Feb 24, 2026 | Rosenbaum Marc Wade | Chief Accounting Officer | SELL | 280 | $140.91 | $39.5K |
12 SEC filing reports analyzed. Sentiment: 2 bullish, 4 bearish, 0 mixed, 6 neutral. Avg impact: 4.6/10.
BULLISH
8-K
5/10
iRhythm Holdings disclosed a binding settlement agreement to resolve a securities class action for $
Jun 5, 2026
NEUTRAL
8-K
2/10
iRhythm Holdings held its 2026 Annual Meeting on May 27, 2026, with 89.69% of shares represented. St
May 28, 2026
NEUTRAL
CLUSTER
2/10
Director Abhijit Talwalkar exercised 5,312 options at $10.71, simultaneously sold 940 shares on the
May 12, 2026
NEUTRAL
144
2/10
Director Abhijit Y. Talwalkar filed a Form 144 notice of intent to sell 5,312 shares of iRhythm Hold
May 11, 2026
BULLISH
PRESS-RELEASE
8/10
iRhythm reported Q1 2026 revenue of $199.4M (+25.7% YoY) and GAAP EPS of -$0.43, beating consensus e
Apr 30, 2026
NEUTRAL
DEFA14A
2/10
iRhythm Holdings, Inc. has filed a definitive proxy statement (DEFA14A) for its upcoming shareholder
Apr 17, 2026
BEARISH
CLUSTER
7/10
Multiple C-suite executives at iRhythm sold shares in a concentrated 7-day window, including CEO Que
Mar 3, 2026
BEARISH
CLUSTER
7/10
Multiple C-suite executives at iRhythm (IRTC) sold shares in a concentrated 3-day window, including
Feb 27, 2026
BEARISH
CLUSTER
7/10
Seven iRhythm executives, including the CEO and other C-suite leaders, sold a combined $7.4 million
Feb 26, 2026
BEARISH
CLUSTER
7/10
iRhythm CEO Quentin Blackford sold $3.46M in shares just after being granted 46,687 non-cash shares,
Feb 26, 2026
NEUTRAL
CLUSTER
3/10
Three insiders at iRhythm Technologies sold or exercised shares within a 7-day window, including two
Feb 26, 2026
NEUTRAL
CLUSTER
3/10
Three insiders at iRhythm Technologies sold or exercised shares in the past week, including two open
Feb 26, 2026
Current analyst consensus: Strong Buy (90% buy). Based on 21 analysts: 9 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$178.93 mean target
+57.4% upside
Strong Buy (1.27)
$147.00 Low
$255.00 High
| Metric | Value |
|---|---|
| Current Price | $113.65 |
| Target Low | $147.00 |
| Target Mean | $178.93 |
| Target Median | $177.50 |
| Target High | $255.00 |
| # Analysts | 14 |
| Recommendation | Strong Buy (1.27) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $-0.10 | $0.12 | 100.2% | +0.0% | — | $0.2B | 17.5% | 10 |
| Next Q 2026-09-30 |
$0.09 | $0.01 | $0.19 | 248.8% | +0.0% | — | $0.2B | 15.0% | 10 |
| Current FY 2026-12-31 |
$0.12 | $-0.12 | $0.30 | 111.3% | -8.6% | 0↑ 1↓ | $0.9B | 17.9% | 10 |
| Next FY 2027-12-31 |
$1.05 | $0.76 | $1.51 | 800.2% | +0.8% | 9↑ 1↓ | $1.0B | 15.7% | 10 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.001 | |
| 7d ago | $0.001 | |
| 30d ago | $0.001 | |
| 60d ago | $-0.096 | +0.096 |
| 90d ago | $-0.096 | +0.096 |
11 analyst firms have rated this stock: 1 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 10, 2026 | BTIG | REITERATE | Buy | Buy |
| Jun 1, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| May 18, 2026 | B of A Securities | MAINTAIN | Buy | Buy |
| May 4, 2026 | Citigroup | MAINTAIN | Buy | Buy |
| May 1, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| May 1, 2026 | JP Morgan | MAINTAIN | Overweight | Overweight |
| May 1, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| May 1, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| May 1, 2026 | Needham | MAINTAIN | Buy | Buy |
| Apr 15, 2026 | Truist Securities | MAINTAIN | Buy | Buy |
| Apr 9, 2026 | Goldman Sachs | MAINTAIN | Neutral | Neutral |
| Apr 6, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Mar 11, 2026 | Citigroup | MAINTAIN | Buy | Buy |
| Feb 23, 2026 | Truist Securities | REITERATE | Buy | Buy |
| Feb 20, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Feb 20, 2026 | JP Morgan | MAINTAIN | Overweight | Overweight |
| Feb 20, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Feb 20, 2026 | Baird | MAINTAIN | Outperform | Outperform |
| Jan 13, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Jan 12, 2026 | Needham | REITERATE | Buy | Buy |
| Jan 5, 2026 | Evercore ISI Group | UPGRADE | In-Line | Outperform |
| Dec 18, 2025 | Truist Securities | MAINTAIN | Buy | Buy |
| Dec 16, 2025 | Baird | MAINTAIN | Outperform | Outperform |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 9 | 10 | 2 | 0 | 0 | 90% | |
| May 1, 2026 | 9 | 10 | 2 | 0 | 0 | 90% | |
| Apr 1, 2026 | 9 | 10 | 2 | 0 | 0 | 90% | |
| Mar 1, 2026 | 9 | 11 | 2 | 0 | 0 | 91% | |
| Feb 1, 2026 | 9 | 10 | 3 | 0 | 0 | 86% | |
| Jan 1, 2026 | 9 | 10 | 3 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 19, 2026
other
iRhythm Holdings to Participate in Upcoming Investor Conferences
<p align="left">SAN FRANCISCO, May 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LzoyZxhVbXTYzDGPIyAppvOZv2Dhyvzk
May 1, 2026
short_volume
Short Volume: IRTC — 58.7% short (0.3M / 0.5M)
Short: 302,938 | Exempt: 1 | TRF Vol: 515,850 | Short Ratio: 58.7% | Off-exchange volume (dark pool + OTC)
Apr 30, 2026
earnings
iRhythm Holdings Announces First Quarter 2026 Financial Results
<p>SAN FRANCISCO, April 30, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=4YB32D3BsI2ig3RhPntXd4gb_aVYWk6GcviX3ix60r4
Apr 30, 2026
earnings_calendar
IRTC Q1 2026 Earnings Scheduled — 2026-04-30
Apr 27, 2026
fda
New Data Presented at HRS 2026 Show Short-Term Holter Monitoring Misses a Large Proportion of AF Recurrence Post-Ablation and Clinically Significant Arrhythmias in Pregnancy
Data presented at HRS 2026 reinforce the clinical value of iRhythm's Zio ambulatory ECG devices and service across diverse patient populations
Apr 16, 2026
earnings
iRhythm Holdings to Report First Quarter 2026 Financial Results on April 30, 2026
<p align="left">SAN FRANCISCO, April 16, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=WZia_TsPRyRia2JLWOzxWdz__lpcXP
Apr 1, 2026
short_interest
FTD: IRTC — 6,233 shares ($0.7M) failed to deliver
Settlement: 20260401, Price: $118.02, FTD Value: $735,618.66, IRHYTHM HLDGS INC COM
Mar 30, 2026
other
Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform
Data presented at ACC.26 demonstrate a high prevalence of clinically actionable arrhythmias across CKM patient populations using Zio® ambulatory ECG
Mar 16, 2026
short_interest
FTD: IRTC — 14,131 shares ($1.6M) failed to deliver
Settlement: 20260316, Price: $113.00, FTD Value: $1,596,803, IRHYTHM HLDGS INC COM
Mar 12, 2026
other
iRhythm Holdings Appoints Jason Patten to its Board of Directors
<p><img alt="Jason Patten" height="220" src="https://ml.globenewswire.com/Resource/Download/4bcdbc81-4743-4f25-bb38-959098796398/jason-patten.jpg" wid
Mar 3, 2026
short_interest
FTD: IRTC — 4,809 shares ($0.6M) failed to deliver
Settlement: 20260303, Price: $128.46, FTD Value: $617,764.14, IRHYTHM HLDGS INC COM
Mar 2, 2026
short_interest
FTD: IRTC — 41,911 shares ($5.6M) failed to deliver
Settlement: 20260302, Price: $133.75, FTD Value: $5,605,596.25, IRHYTHM HLDGS INC COM